These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 8228824

  • 1. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
    Wu Y, Guo Y, Liu Y.
    J Exp Med; 1993 Nov 01; 178(5):1789-93. PubMed ID: 8228824
    [Abstract] [Full Text] [Related]

  • 2. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 3. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C, Damle NK.
    J Exp Med; 1992 Dec 01; 176(6):1595-604. PubMed ID: 1334116
    [Abstract] [Full Text] [Related]

  • 4. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
    Freeman GJ, Borriello F, Hodes RJ, Reiser H, Gribben JG, Ng JW, Kim J, Goldberg JM, Hathcock K, Laszlo G.
    J Exp Med; 1993 Dec 01; 178(6):2185-92. PubMed ID: 7504059
    [Abstract] [Full Text] [Related]

  • 5. Expression and functional significance of an additional ligand for CTLA-4.
    Lenschow DJ, Su GH, Zuckerman LA, Nabavi N, Jellis CL, Gray GS, Miller J, Bluestone JA.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11054-8. PubMed ID: 7504292
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y, Wu Y, Zhao M, Kong XP, Liu Y.
    J Exp Med; 1995 Apr 01; 181(4):1345-55. PubMed ID: 7535334
    [Abstract] [Full Text] [Related]

  • 7. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.
    Razi-Wolf Z, Galvin F, Gray G, Reiser H.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11182-6. PubMed ID: 7504299
    [Abstract] [Full Text] [Related]

  • 8. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ, Bajorath J, Brady W, Leytze G, Greene J, Naemura J, Linsley PS.
    J Exp Med; 1994 Dec 01; 180(6):2049-58. PubMed ID: 7964482
    [Abstract] [Full Text] [Related]

  • 9. CTLA-4 is a second receptor for the B cell activation antigen B7.
    Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA.
    J Exp Med; 1991 Sep 01; 174(3):561-9. PubMed ID: 1714933
    [Abstract] [Full Text] [Related]

  • 10. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
    Freeman GJ, Borriello F, Hodes RJ, Reiser H, Hathcock KS, Laszlo G, McKnight AJ, Kim J, Du L, Lombard DB.
    Science; 1993 Nov 05; 262(5135):907-9. PubMed ID: 7694362
    [Abstract] [Full Text] [Related]

  • 11. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L, Shevach EM.
    Eur J Immunol; 1994 Apr 05; 24(4):859-66. PubMed ID: 7512033
    [Abstract] [Full Text] [Related]

  • 12. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA, Oosterwegel MA, Shimizu K, Yamada A, Freeman GJ, Mitchell RN, Sayegh MH, Sharpe AH.
    J Clin Invest; 2001 Apr 05; 107(7):881-7. PubMed ID: 11285307
    [Abstract] [Full Text] [Related]

  • 13. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11059-63. PubMed ID: 7504293
    [Abstract] [Full Text] [Related]

  • 14. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.
    Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN.
    J Immunol; 2001 Mar 01; 166(5):3107-13. PubMed ID: 11207262
    [Abstract] [Full Text] [Related]

  • 15. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen.
    Lew AM, Brady JL, Silva A, Coligan JE, Georgiou HM.
    Transplantation; 1996 Jul 15; 62(1):83-9. PubMed ID: 8693551
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.
    Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA.
    Science; 1992 Aug 07; 257(5071):792-5. PubMed ID: 1496399
    [Abstract] [Full Text] [Related]

  • 17. CD28-specific antibody prevents graft-versus-host disease in mice.
    Yu XZ, Bidwell SJ, Martin PJ, Anasetti C.
    J Immunol; 2000 May 01; 164(9):4564-8. PubMed ID: 10779758
    [Abstract] [Full Text] [Related]

  • 18. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB.
    Immunity; 1994 Sep 01; 1(6):501-8. PubMed ID: 7534617
    [Abstract] [Full Text] [Related]

  • 19. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP.
    DeBenedette MA, Chu NR, Pollok KE, Hurtado J, Wade WF, Kwon BS, Watts TH.
    J Exp Med; 1995 Mar 01; 181(3):985-92. PubMed ID: 7532686
    [Abstract] [Full Text] [Related]

  • 20. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
    Haffar OK, Smithgall MD, Bradshaw J, Brady B, Damle NK, Linsley PS.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11094-8. PubMed ID: 7504294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.